Skip to main content
Clinical Trials/NCT02741206
NCT02741206
Withdrawn
Not Applicable

Bellevue ROSE: Preventing Postpartum Depression in Prenatal Care

NYU Langone Health1 site in 1 countryJune 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Post-partum Depression
Sponsor
NYU Langone Health
Locations
1
Primary Endpoint
Depression severity measured by Patient Health Questionnaire (PHQ-9)
Status
Withdrawn
Last Updated
8 years ago

Overview

Brief Summary

This is randomized control trial of a brief intervention called Bellevue ROSE (Reach Out Stay Strong Essentials). Bellevue ROSE is a manualized and highly structured interpersonal intervention that provides women with psycho-education about maternal depression and strategies for strengthening social support and connectedness. Investigators use motivational interviewing strategies to improve treatment compliance and resource acquisition

Registry
clinicaltrials.gov
Start Date
June 2016
End Date
July 20, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • English speaking
  • Women who score between 5-19 on the PHQ-9 and \>23 on the ANRQ

Exclusion Criteria

  • Women who score \<5 or \>19 on the PHQ-9
  • Women who are currently suicidal, active substance users, currently experiencing domestic violence, or have a current or past history of bipolar or psychotic disorder diagnosis.
  • Women who are currently in treatment for psychotherapy.
  • Unable to speak and/or understand English proficiently
  • Unable to provide informed consent

Outcomes

Primary Outcomes

Depression severity measured by Patient Health Questionnaire (PHQ-9)

Time Frame: 6 Months

Measure of perceived social support measured by Multidimensional Scale of Perceived Social Support (MSPSS)

Time Frame: 6 Months

Measure of stress using Perceived Stress Index (PSS)

Time Frame: 6 Months

Parenting Practices and treatment assessed by Parenting Practices and Treatment Questionnaire

Time Frame: 6 Months

Measure of psycho social risk assessment according to Adapted antenatal Risk Questionnaire (ANRQ)

Time Frame: Screening

Study Sites (1)

Loading locations...

Similar Trials